Abstracts - faqs.org

Abstracts

Pharmaceuticals and cosmetics industries

Search abstracts:
Abstracts » Pharmaceuticals and cosmetics industries

Three new cyclopentanoid monoterpenes from Picrorhiza scrophulariiflora

Article Abstract:

The root of the Picrorhiza scrophulariiflora plant is used in traditional Chinese medicine for the treatment of jaundice, dysentry, and others. A study is made that describes the isolation and structural elucidation of three new cyclopentanoid monoterpenes, named piscrocins A, B and C, from the ethanol extracts of these roots.

Author: Hao Wang, Wen-Cai Ye, Ren-Wang Jiang, Jia-Jun Wu, Xin-Sheng Yao, Shou-Xun Zhao, Mak, Thomas C.W.
Publisher: Georg Thieme Verlag
Publication Name: Planta Medica
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0032-0943
Year: 2004
Cyclic Crude and Intermediate Manufacturing, Cyclopentadiene, Scrophulariaceae

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Kava does not display metabolic toxicity in a homogenous cellular assay

Article Abstract:

A study was conducted to determine whether the presence of drug-metabolizing enzymes would increase kava's toxicity to cells. The method of study and its findings are discussed, which suggests that vitro kava does not appear to be activated to toxic metabolites by enzymes known to be important in metabolic toxicity.

Author: Zou, Lihong, Harkey, Martha R., Henderson, Gary L., Dike, Laura E.
Publisher: Georg Thieme Verlag
Publication Name: Planta Medica
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0032-0943
Year: 2004
Kava plant, Kava (Plant)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Research, United States, Medicinal plants
Similar abstracts:
  • Abstracts: allo-aromadendrane-and picrotoxane-type sesquiterpenes from Dendrobium moniliforme. Demethylbellidifolin inhibits adhesion of monocytes to endothelial cells via reduction of tumor necrosis factor alpha and endogenous nitric oxide synthase inhibitor level
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.